CZ308081B6 - Rekombinantní glykoproteiny a způsob jejich výroby - Google Patents

Rekombinantní glykoproteiny a způsob jejich výroby Download PDF

Info

Publication number
CZ308081B6
CZ308081B6 CZ2008-404A CZ2008404A CZ308081B6 CZ 308081 B6 CZ308081 B6 CZ 308081B6 CZ 2008404 A CZ2008404 A CZ 2008404A CZ 308081 B6 CZ308081 B6 CZ 308081B6
Authority
CZ
Czechia
Prior art keywords
fucosyltransferase
glcnac
sequence
activity
plant cells
Prior art date
Application number
CZ2008-404A
Other languages
Czech (cs)
English (en)
Inventor
Friedrich Altmann
Original Assignee
Friedrich Altmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3486087&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CZ308081(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Friedrich Altmann filed Critical Friedrich Altmann
Publication of CZ308081B6 publication Critical patent/CZ308081B6/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/18Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CZ2008-404A 1999-02-18 2000-02-17 Rekombinantní glykoproteiny a způsob jejich výroby CZ308081B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0027099A AT408446B (de) 1999-02-18 1999-02-18 Fucosyltransferase-gen

Publications (1)

Publication Number Publication Date
CZ308081B6 true CZ308081B6 (cs) 2019-12-27

Family

ID=3486087

Family Applications (2)

Application Number Title Priority Date Filing Date
CZ2008-404A CZ308081B6 (cs) 1999-02-18 2000-02-17 Rekombinantní glykoproteiny a způsob jejich výroby
CZ20012943A CZ299622B6 (cs) 1999-02-18 2000-02-17 Molekula DNA kódující fukosyltransferázu

Family Applications After (1)

Application Number Title Priority Date Filing Date
CZ20012943A CZ299622B6 (cs) 1999-02-18 2000-02-17 Molekula DNA kódující fukosyltransferázu

Country Status (29)

Country Link
US (3) US20080234471A1 (enExample)
EP (3) EP2062977B1 (enExample)
JP (2) JP5514386B2 (enExample)
KR (1) KR20010108234A (enExample)
CN (1) CN1360633A (enExample)
AT (2) AT408446B (enExample)
AU (1) AU771995B2 (enExample)
BG (1) BG65140B1 (enExample)
BR (1) BR0010114A (enExample)
CA (1) CA2362964C (enExample)
CZ (2) CZ308081B6 (enExample)
DE (1) DE50011116D1 (enExample)
DK (2) DK2062977T3 (enExample)
EE (1) EE200100432A (enExample)
ES (2) ES2246222T3 (enExample)
HR (1) HRP20010681A2 (enExample)
HU (1) HU230075B1 (enExample)
IL (2) IL144777A0 (enExample)
IS (1) IS6041A (enExample)
MX (1) MXPA01008372A (enExample)
NO (1) NO20013993L (enExample)
NZ (1) NZ513685A (enExample)
PL (2) PL205710B1 (enExample)
PT (1) PT2062977E (enExample)
SK (1) SK286416B6 (enExample)
TR (1) TR200102393T2 (enExample)
WO (1) WO2000049153A1 (enExample)
YU (1) YU58901A (enExample)
ZA (1) ZA200106735B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2350063T3 (es) 1998-12-09 2011-01-17 Phyton Holdings, Llc Método para fabricación de glicoproteínas que tienen glicosilación de tipo humano.
AT408446B (de) * 1999-02-18 2001-11-26 Altmann Friedrich Dr Fucosyltransferase-gen
ES2568899T3 (es) 1999-04-09 2016-05-05 Kyowa Hakko Kirin Co., Ltd. Procedimiento para controlar la actividad de una molécula inmunofuncional
NZ518532A (en) 1999-10-26 2004-02-27 Plant Res Internat B Transgenic plant expressing mammalian beta-1,4- galactosyltransferase
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
CA2434364C (en) 2001-01-19 2013-03-19 The Dow Chemical Company Method for secretory production of glycoprotein having human-type sugar chain using plant cell
WO2003078614A2 (en) 2002-03-19 2003-09-25 Plant Research International B.V. Gntiii (udp-n-acethylglucosamine:beta-d mannoside beta (1,4)-n-acethylglucosaminy ltransferase iii) expression in plants
CA2799805C (en) 2002-03-19 2016-05-17 Stichting Dienst Landbouwkundig Onderzoek Optimizing glycan processing in plants
AU2003236020B2 (en) * 2002-04-09 2009-03-19 Kyowa Hakko Kirin Co., Ltd. Cell with depression or deletion of the activity of protein participating in GDP-fucose transport
CL2003002461A1 (es) 2002-11-27 2005-01-07 Dow Chemical Company Agroscien Inmunoglobulina que comprende al menos un glicano afucosilado, composicion que la contiene, secuencia nucleotidica y vector que la comprende, procedimiento para producir dicha inmunoglobulina en plantas.
ATE426033T1 (de) 2003-08-11 2009-04-15 Greenovation Biotech Gmbh Promoter sequenzen aus moos und dessen verwendung
FI20055398A0 (fi) 2005-07-08 2005-07-08 Suomen Punainen Risti Veripalv Menetelmä solupopulaatioiden evaluoimiseksi
US20090060921A1 (en) * 2006-01-17 2009-03-05 Biolex Therapeutics, Inc. Glycan-optimized anti-cd20 antibodies
MX2008009220A (es) 2006-01-17 2008-10-10 Biolex Therapeutics Inc Composiciones y metodos para la humanizacion y optimizacion de n-glicanos en plantas.
CN102094019B (zh) * 2007-01-15 2012-11-28 燕秋 用于抑制LeY糖抗原合成的岩藻糖基转移酶Ⅳ的RNA干涉序列及重组干涉质粒
CN102094020B (zh) * 2007-01-15 2012-11-28 燕秋 用于抑制LeY糖抗原合成的岩藻糖基转移酶I的RNA干涉序列及重组干涉质粒
CN101702919B (zh) 2007-04-17 2014-08-13 基金会农业研究服务中心 植物通过表达非哺乳动物糖基转移酶而表现出哺乳动物类型的糖基化作用
JP5766947B2 (ja) * 2007-09-07 2015-08-19 チルドレンズ ホスピタル メディカル センター 臨床サンプルにおける分泌性のルイス抗原およびシアル化抗原のレベルの疾患リスクの予測指標としての使用
WO2009056155A1 (en) * 2007-10-31 2009-05-07 Bayer Bioscience N.V. Method to produce modified plants with altered n-glycosylation pattern
EP2166085A1 (en) 2008-07-16 2010-03-24 Suomen Punainen Risti Veripalvelu Divalent modified cells
PL2944690T3 (pl) 2010-10-11 2018-05-30 Jennewein Biotechnologie Gmbh Nowe fukozylotransferazy i ich zastosowanie
KR101293658B1 (ko) * 2010-12-30 2013-08-07 대한민국 알파-1,3-푸코실트랜스퍼라아제 및/또는 베타-1,2-자일로실트렌스퍼라아제 유전자를 포함하는 벼 형질전환용 벡터 및 형질전환된 벼
ES2439507T3 (es) * 2011-01-20 2014-01-23 Jennewein Biotechnologie Gmbh Fucosiltransferasas novedosas y sus aplicaciones
EP2789686A1 (en) 2013-04-11 2014-10-15 Greenovation Biotech GmbH Expression of phosphorylated glycoproteins in plants
EP3050973A1 (en) * 2015-01-30 2016-08-03 Jennewein Biotechnologie GmbH Fermentation process for producing monosaccharides in free form from nucleotide-activated sugars
CN110317799A (zh) * 2019-07-18 2019-10-11 江南大学 一种人源岩藻糖转移酶8的原核表达方法及其产品
EP3871687A1 (en) 2020-02-27 2021-09-01 eleva GmbH Enzyme replacement therapy for treating pompe disease

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997009421A1 (en) * 1995-09-08 1997-03-13 The Regents Of The University Of Michigan Chimeric fucosyltransferase polypeptides and nucleic acid sequences encoding them

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272066A (en) 1986-03-07 1993-12-21 Massachusetts Institute Of Technology Synthetic method for enhancing glycoprotein stability
DE69434749T2 (de) 1993-03-29 2007-04-26 Kyowa Hakko Kogyo Co., Ltd. Alpha-1,3-Fucosyltransferase
US6509149B2 (en) * 1995-06-06 2003-01-21 Hybridon, Inc. HPV-specific oligonucleotides
AT408446B (de) * 1999-02-18 2001-11-26 Altmann Friedrich Dr Fucosyltransferase-gen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997009421A1 (en) * 1995-09-08 1997-03-13 The Regents Of The University Of Michigan Chimeric fucosyltransferase polypeptides and nucleic acid sequences encoding them

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GRABENHORST E. et al.: „Genetic engineering of recombinant glycoproteins and the glycosylation pathway in mammalian host cells", Glycoconjugate Journal, vol. 16, no. 2, únor 1999, str. 81 - 97, ISSN 0282-0080 *
LEROUGE P. et al.: „N-Glycoprotein biosynthesis in plants: recent developments and future trends", Plant Molecular Biology, vol. 38, 1998, str. 31 - 48, ISSN 0167-4412 *
SCHAEWEN VON A. et al.: „Isolation of a mutant Arabidopsis plant that lacks N-acetyl-glucosaminyl transferase I and is unable to synthesize Golgi-modified complex N-linked glycans", Plant Physiology, vol. 102, 1993, str. 1109 - 1118, ISSN 0032-0889 *
WAGNER R. et al.: „N-Acetyl-β-glucosaminidase accounts for differences in glycosylation of influenza virus hemagglutinin expressed in insect cells from baculovirus vector ", Journal of Virology, vol. 70, no. 6, 1996, str. 4103 - 4109, ISSN 0022-538X *

Also Published As

Publication number Publication date
NZ513685A (en) 2001-09-28
KR20010108234A (ko) 2001-12-07
NO20013993L (no) 2001-10-17
EP1151109A1 (de) 2001-11-07
ES2246222T3 (es) 2006-02-16
HU230075B1 (hu) 2015-06-29
HUP0200394A2 (hu) 2002-05-29
HUP0200394A3 (en) 2006-06-28
BG65140B1 (bg) 2007-03-30
IL144777A0 (en) 2002-06-30
DK2062977T3 (da) 2014-04-07
ES2444126T3 (es) 2014-02-24
HRP20010681A2 (en) 2003-08-31
AT408446B (de) 2001-11-26
AU771995B2 (en) 2004-04-08
EE200100432A (et) 2002-12-16
US8895806B2 (en) 2014-11-25
PT2062977E (pt) 2014-04-07
US20090199306A1 (en) 2009-08-06
BR0010114A (pt) 2002-06-04
TR200102393T2 (tr) 2002-04-22
IL144777A (en) 2007-12-03
US8198078B2 (en) 2012-06-12
EP1151109B1 (de) 2005-09-07
IS6041A (is) 2001-08-08
CZ299622B6 (cs) 2008-09-24
CZ20012943A3 (cs) 2002-04-17
JP5514386B2 (ja) 2014-06-04
SK11182001A3 (sk) 2002-01-07
PL363438A1 (en) 2004-11-15
DK1151109T3 (da) 2006-01-16
CN1360633A (zh) 2002-07-24
NO20013993D0 (no) 2001-08-16
WO2000049153A1 (de) 2000-08-24
EP2062977A1 (de) 2009-05-27
JP2011120592A (ja) 2011-06-23
EP2062977B1 (de) 2014-01-08
CA2362964C (en) 2012-03-27
US20130212740A1 (en) 2013-08-15
US20080234471A1 (en) 2008-09-25
MXPA01008372A (es) 2003-06-06
ATA27099A (de) 2001-04-15
DE50011116D1 (en) 2005-10-13
CA2362964A1 (en) 2000-08-24
ZA200106735B (en) 2002-08-15
BG105899A (en) 2002-12-29
EP1642979A1 (de) 2006-04-05
ATE304053T1 (de) 2005-09-15
AU2646000A (en) 2000-09-04
SK286416B6 (sk) 2008-09-05
PL205710B1 (pl) 2010-05-31
YU58901A (sh) 2004-03-12
JP2002536978A (ja) 2002-11-05
PL205785B1 (pl) 2010-05-31

Similar Documents

Publication Publication Date Title
CZ308081B6 (cs) Rekombinantní glykoproteiny a způsob jejich výroby
CA2348366A1 (en) Nucleic acid molecules from rice and their use for the production of modified starch
HU0303421D0 (en) Dna molecules that code for enzymes involved in strach synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules
AU7659298A (en) Recombinant lactoferrin, methods of production from plants and uses
JP2002536978A5 (enExample)
CA2461443A1 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
CA2102702A1 (en) Vitamin K-Dependent Carboxylase
WO2001044276A3 (en) Moss genes from physcomitrella patens encoding proteins involved in the synthesis of tocopherols carotenoids and aromatic amino acids
CA2266421A1 (en) Genes coding for a protein having glycoside transfer activity
NZ334517A (en) Antifungal plant proteins and method of inhibiting fungal growth with carbohydrate oxidising activity and DNA coding sequences thereof
Woessner et al. Domain conservation in several volvocalean cell wall proteins
US5585474A (en) DNA encoding protein possessing metastasis-inhibitory activity
Amitai-Zeigerson et al. Genomic nucleotide sequence of tomato Asr2, a second member of the stress/ripening-induced Asr1 gene family
CA2348025A1 (en) Genes encoding proteins regulating ph of vacuoles
BR9911074A (pt) Genes codificadores para polipeptidas de ß-galactosidase de tomates
DE11151437T1 (de) Genetisch aufbereitetes Gellan
US7226997B2 (en) Mast cell-specific signal transducer and cDNA thereof
GB2455255A (en) Galactosyltransferase
PT1272642E (pt) Mananase de café.
ATE226256T1 (de) Antifungale proteine, dafür kodierende dna, und diese enthaltende wirtzelle
EP1543127B1 (de) Für proteinspaltende enzyme in form von spezifischen proteasen kodierende nukleinsäuresequenzen, zugehörige polypeptide und verwendung von allen
CA2591790A1 (en) Genes coding for flavone synthases
Dyer et al. Genetic Control of Photosynthate Metabolism
Pawlowski et al. Actinorhizal nodules
Sartore et al. Three myosin heavy chain isoforms in human smooth muscle

Legal Events

Date Code Title Description
MK4A Patent expired

Effective date: 20200217